X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2937) 2937
Publication (154) 154
Newsletter (13) 13
Book Chapter (7) 7
Book Review (4) 4
Conference Proceeding (3) 3
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (2522) 2522
mice (2052) 2052
fibrosarcoma - immunology (1673) 1673
female (1037) 1037
male (766) 766
humans (716) 716
neoplasm transplantation (688) 688
fibrosarcoma - pathology (673) 673
mice, inbred balb c (639) 639
oncology (513) 513
mice, inbred c57bl (477) 477
fibrosarcoma (476) 476
sarcoma, experimental - immunology (438) 438
immunology (424) 424
fibrosarcoma - therapy (403) 403
index medicus (401) 401
fibrosarcoma - chemically induced (387) 387
mice, inbred c3h (368) 368
rats (345) 345
neoplasms, experimental - immunology (342) 342
tumor cells, cultured (341) 341
methylcholanthrene (340) 340
cancer (333) 333
t-lymphocytes - immunology (295) 295
cell line (290) 290
spleen - immunology (273) 273
tumors (270) 270
immunotherapy (259) 259
cell line, tumor (228) 228
cytotoxicity, immunologic (227) 227
macrophages - immunology (218) 218
fibrosarcoma - drug therapy (214) 214
fibrosarcoma - metabolism (212) 212
cells, cultured (207) 207
expression (197) 197
immunity, cellular (197) 197
time factors (186) 186
cell biology (183) 183
transplantation, homologous (183) 183
research article (180) 180
mice, nude (170) 170
immunization (166) 166
fibrosarcoma - genetics (165) 165
lymphocytes - immunology (165) 165
mice, inbred strains (164) 164
sarcoma (163) 163
antigens, neoplasm - immunology (158) 158
antigens, neoplasm (146) 146
killer cells, natural - immunology (143) 143
t-lymphocytes, cytotoxic - immunology (138) 138
neoplasm metastasis (137) 137
cytotoxicity tests, immunologic (131) 131
transfection (131) 131
spleen - cytology (130) 130
lymphocyte activation (128) 128
immunity (126) 126
apoptosis (125) 125
biochemistry & molecular biology (122) 122
cells (122) 122
lung neoplasms - secondary (122) 122
immunosuppression (120) 120
research (120) 120
medicine, research & experimental (119) 119
proteins (115) 115
cell transformation, neoplastic (112) 112
in-vivo (110) 110
lung neoplasms - immunology (110) 110
multidisciplinary sciences (110) 110
pathology (109) 109
metastasis (108) 108
lymph nodes - immunology (107) 107
antigens (106) 106
activation (102) 102
sarcoma, experimental - chemically induced (102) 102
immunohistochemistry (101) 101
sarcoma, experimental - pathology (101) 101
sarcoma, experimental - therapy (101) 101
t-lymphocytes, regulatory - immunology (101) 101
mice, inbred cba (99) 99
immunization, passive (98) 98
transplantation immunology (98) 98
flow cytometry (97) 97
lymphocytes (97) 97
medicine (96) 96
analysis (89) 89
growth (87) 87
t-cells (85) 85
rats, inbred strains (84) 84
fluorescent antibody technique (83) 83
gene expression (83) 83
neoplasms - immunology (81) 81
neoplasms, experimental - pathology (81) 81
antigens, neoplasm - analysis (80) 80
macrophages (80) 80
immune sera (79) 79
science (79) 79
antineoplastic agents - pharmacology (78) 78
dendritic cells (78) 78
graft rejection (78) 78
kinetics (78) 78
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2839) 2839
Japanese (56) 56
French (18) 18
Chinese (11) 11
Russian (10) 10
German (9) 9
Italian (5) 5
Spanish (3) 3
Croatian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Immunology, ISSN 0022-1767, 11/2002, Volume 169, Issue 10, pp. 5715 - 5725
IL-12 is a principal activator of both innate and adaptive immunity against infections agents and malignancies. Regulation of proinflammatory IL-12 gene... 
MULTIPLE-MYELOMA | CELLS | SITE | ACTIVATION | JUN | INTERLEUKIN-12 P40 PROMOTER | NUCLEAR ONCOPROTEIN | FOS | IMMUNOLOGY | PROTEINS | NF-KAPPA-B | Transcriptional Activation - genetics | Interleukin-12 Subunit p35 | Humans | Monocytes - immunology | Transcriptional Activation - immunology | Interleukin-4 - physiology | Interleukin-12 - biosynthesis | Protein Subunits - genetics | DNA-Binding Proteins - physiology | Proto-Oncogene Proteins c-maf | Gene Expression Regulation, Neoplastic - immunology | Interleukin-12 - metabolism | Proto-Oncogene Proteins - deficiency | Down-Regulation - genetics | Response Elements - immunology | Mice, Knockout | Fibrosarcoma - genetics | Macrophages - metabolism | Up-Regulation - immunology | Nucleoproteins - metabolism | Interleukin-10 - genetics | Mice | Protein Subunits - antagonists & inhibitors | Interleukin-12 Subunit p40 | Macrophage Activation - genetics | Interleukin-12 - genetics | Fibrosarcoma - immunology | Monocytes - metabolism | Proto-Oncogene Proteins - biosynthesis | DNA-Binding Proteins - deficiency | Interleukin-10 - physiology | Protein Subunits - metabolism | DNA-Binding Proteins - metabolism | Interleukin-12 - antagonists & inhibitors | Female | Fetus | Macrophages - immunology | Cell Line | Mice, Inbred C57BL | Cells, Cultured | Proto-Oncogene Proteins - genetics | Up-Regulation - genetics | Protein Structure, Tertiary - genetics | DNA-Binding Proteins - genetics | Leucine Zippers - genetics | Animals | Down-Regulation - immunology | NF-kappa B - physiology | Proto-Oncogene Proteins - physiology | Interleukin-10 - biosynthesis | Promoter Regions, Genetic - immunology | DNA-Binding Proteins - biosynthesis
Journal Article
Journal Article
Journal Article
European Journal of Immunology, ISSN 0014-2980, 12/2007, Volume 37, Issue 12, pp. 3381 - 3392
Treatment of tumor‐bearing mice with mouse (m)TNF‐α, targeted to tumor vasculature by the anti‐ED‐B fibronectin domain antibody L19(scFv) and combined with... 
Antitumor immunity | CD4 priming | Th1/Th2 cells | TNF‐α | Melphalan | TNF-α | IMMUNE-RESPONSE | melphalan | TNF-alpha | DENDRITIC CELL | CANCER-IMMUNOTHERAPY | IMMUNOLOGY | antitumor immunity | INTERFERON-GAMMA | KILLER-CELL | REGULATORY T-CELLS | BLOOD-VESSELS | ED-B DOMAIN | MAMMARY ADENOCARCINOMA CELLS | Fibrosarcoma - blood supply | Vaccination | Fibrosarcoma - immunology | Antineoplastic Agents, Alkylating - administration & dosage | Lymphocyte Depletion | Melphalan - therapeutic use | Immunoconjugates - administration & dosage | Drug Delivery Systems | CD4-Positive T-Lymphocytes - immunology | Immunoconjugates - therapeutic use | Neovascularization, Pathologic - therapy | T-Lymphocytes, Cytotoxic - immunology | Lymphocyte Activation | Adenocarcinoma - immunology | Fibrosarcoma - therapy | Combined Modality Therapy | Mice, SCID | Adenocarcinoma - drug therapy | Adenocarcinoma - blood supply | Antineoplastic Agents, Alkylating - therapeutic use | Tumor Necrosis Factor-alpha - therapeutic use | Melphalan - administration & dosage | Animals | Immunoglobulin Fragments - immunology | Adenocarcinoma - therapy | Colonic Neoplasms - pathology | Immunoglobulin Fragments - administration & dosage | Tumor Necrosis Factor-alpha - administration & dosage | Immunologic Memory | Mice | Mice, Inbred BALB C | Fibrosarcoma - drug therapy | Drug Screening Assays, Antitumor | Lymphocytes, Tumor-Infiltrating - immunology
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 02/2018, Volume 65, Issue 2, pp. e26813 - n/a
Journal Article
The Journal of Immunology, ISSN 0022-1767, 04/2004, Volume 172, Issue 7, pp. 4215 - 4224
Peptide vaccination is an immunotherapeutic strategy being pursued as a method of enhancing Ag-specific antitumor responses. To date, most studies have focused... 
MHC CLASS-I | MELANOMA ANTIGEN | METASTATIC MELANOMA | TUMOR-SPECIFIC CD4(+) | CANCER-PATIENTS | DENDRITIC CELLS | CD8-T-CELL MEMORY | IMMUNOLOGY | LYMPHOCYTE RESPONSE | OPTIMAL INDUCTION | ADOPTIVE IMMUNOTHERAPY | CD8-Positive T-Lymphocytes - cytology | Neoplasm Transplantation | Stem Cells - immunology | Adjuvants, Immunologic - administration & dosage | CD8-Positive T-Lymphocytes - transplantation | Molecular Sequence Data | Epitopes, T-Lymphocyte - administration & dosage | Fibrosarcoma - immunology | Interphase - immunology | Stem Cells - cytology | Antineoplastic Agents - administration & dosage | T-Lymphocytes, Regulatory - immunology | Lymphocyte Activation - immunology | Fibrosarcoma - pathology | Cell Division - immunology | Injections, Subcutaneous | Female | Epitopes, T-Lymphocyte - immunology | Cell Division - genetics | Amino Acid Sequence | CD4 Antigens - immunology | CD40 Antigens - physiology | Antineoplastic Agents - immunology | Cancer Vaccines - administration & dosage | Mice, Transgenic | CD4 Antigens - administration & dosage | Vaccines, Subunit - immunology | Mice, SCID | Mice, Knockout | Cancer Vaccines - immunology | Animals | Vaccines, Subunit - administration & dosage | Cell Line, Tumor | Lymphocyte Count | Mice | Mice, Inbred BALB C | Interphase - genetics | CD8-Positive T-Lymphocytes - immunology | Fibrosarcoma - prevention & control
Journal Article
Journal Article
Journal Article
Cancer Research, ISSN 0008-5472, 09/2015, Volume 75, Issue 18, pp. 3812 - 3822
STAT3 is an oncogenic transcription factor with potent immunosuppressive functions. We found that pharmacologic inhibition of STAT3 or its selective knockout... 
IMMUNITY | RECRUITMENT | ACTIVATION | ONCOLOGY | IMMUNOTHERAPY | RESISTANCE | DEATH | DIFFERENTIATION | TRANSCRIPTION FACTOR STAT3 | TUMORS | T-CELLS | Doxorubicin - therapeutic use | Cyclic S-Oxides - administration & dosage | Antibiotics, Antineoplastic - pharmacology | Chemokine CXCL9 - biosynthesis | Dendritic Cells - immunology | Neoplasm Proteins - physiology | Transcriptional Activation | Fibrosarcoma - immunology | Neoplasm Proteins - antagonists & inhibitors | Receptor, Interferon alpha-beta - antagonists & inhibitors | Interferon Type I - biosynthesis | Chemokine CXCL10 - biosynthesis | Colorectal Neoplasms - therapy | STAT3 Transcription Factor - physiology | Colorectal Neoplasms - drug therapy | Female | Cyclic S-Oxides - pharmacology | Immunocompetence | Receptors, CXCR3 - antagonists & inhibitors | Gene Expression Regulation, Neoplastic - drug effects | Neoplasm Proteins - genetics | STAT3 Transcription Factor - genetics | Doxorubicin - administration & dosage | T-Lymphocytes, Cytotoxic - immunology | Neoplasm Proteins - biosynthesis | Mice, Inbred C57BL | Fibrosarcoma - therapy | Combined Modality Therapy | Chemokine CXCL9 - genetics | Antibiotics, Antineoplastic - administration & dosage | Drug Synergism | Cyclic S-Oxides - therapeutic use | Animals | Colorectal Neoplasms - immunology | Antibiotics, Antineoplastic - therapeutic use | Signal Transduction - drug effects | Chemokine CXCL10 - genetics | Mice, Nude | Receptors, CXCR3 - physiology | Cell Line, Tumor | Interferon Type I - genetics | Mice | Mice, Inbred BALB C | STAT3 Transcription Factor - antagonists & inhibitors | Doxorubicin - pharmacology | Fibrosarcoma - drug therapy | Lymphocytes, Tumor-Infiltrating - immunology
Journal Article
Journal Article
The Journal of Immunology, ISSN 0022-1767, 08/2005, Volume 175, Issue 3, pp. 1424 - 1432
Journal Article